Entero HealthcareTechnical View (Price Action)
The stock has been under pressure for the past few months, sliding down from the ₹1,400–₹1,425 area to recent lows around ₹950–₹970. In the latest move, it found strong buying support near ₹970 and has bounced back above ₹1,000, with the recent close around ₹1,025–₹1,030. This bounce also coincides with a break above the short-term falling trendline, suggesting the first signs of a possible trend reversal from the lower end of the channel. For now, the ₹970–₹987 zone acts as an important support area, while the next resistance levels to watch are around ₹1,070–₹1,100. A sustained move above ₹1,100, along with a higher-low structure, would meaningfully improve the medium-term outlook.
Fundamental View (Business & Numbers)
Entero Healthcare is a pharma and healthcare distribution company that has been scaling up its business through network expansion and acquisitions. Its revenues have been growing well, but profitability is still on the lower side, with thin operating margins that are typical for the distribution segment. The business has growth visibility, but the market remains slightly cautious because return ratios are moderate and acquisition-led expansion brings some execution risk. Going ahead, steady improvement in EBITDA margins, stronger cash-flow generation, and more consistent earnings delivery will be key factors that could drive a positive re-rating in the stock.
Like, comment your thoughts, and share this post
Explore more stock ideas on the right hand side your feedback means a lot to me!
Disclaimer: This post is for educational purposes only and should not be considered a buy/sell recommendation.
